| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11248-005-1771-0 |
| P698 | PubMed publication ID | 16315090 |
| P50 | author | Eric Soler | Q51099473 |
| P2093 | author name string | Jean Cohen | |
| Louis-Marie Houdebine | |||
| Cynthia Fourgeux | |||
| Isabelle Schwartz-Cornil | |||
| Bruno Passet | |||
| Annie Charpilienne | |||
| Christine Merle | |||
| Agnès Le Saux | |||
| Antoine Piriou | |||
| Frédéric Guinut | |||
| Ruxandra Cohen | |||
| Véronique Sorel | |||
| P2860 | cites work | Sequence differences between glycosylated and non-glycosylated Asn-X-Thr/Ser acceptor sites: implications for protein engineering | Q57381679 |
| Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity | Q70998772 | ||
| Human acid alpha-glucosidase from rabbit milk has therapeutic effect in mice with glycogen storage disease type II | Q73142656 | ||
| Withdrawal of rotavirus vaccine recommendation | Q73217916 | ||
| Immune responses and protection obtained with rotavirus VP6 DNA vaccines given by intramuscular injection | Q73781444 | ||
| Oral immunization with rotavirus VP7 expressed in transgenic potatoes induced high titers of mucosal neutralizing IgA | Q73897782 | ||
| Production of immunogenic VP6 protein of bovine group A rotavirus in transgenic potato plants | Q74446677 | ||
| Position-independent and tissue-specific expression of porcine whey acidic protein gene from a bacterial artificial chromosome in transgenic mice | Q74690747 | ||
| Serotype classification and characterisation of the rotavirus SA11 VP6 protein using mass spectrometry and two-dimensional gel electrophoresis | Q77494558 | ||
| Vaccines. Rotavirus vaccines' second chance | Q80788121 | ||
| Atomic structure of the major capsid protein of rotavirus: implications for the architecture of the virion | Q27630969 | ||
| The human growth hormone gene family: nucleotide sequences show recent divergence and predict a new polypeptide hormone | Q28279628 | ||
| Nasal immunization of mice with virus-like particles protects offspring against rotavirus diarrhea | Q33604308 | ||
| Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity | Q33785446 | ||
| Functional mapping of protective domains and epitopes in the rotavirus VP6 protein | Q33812420 | ||
| Rotavirus 2/6 virus-like particles administered intranasally in mice, with or without the mucosal adjuvants cholera toxin and Escherichia coli heat-labile toxin, induce a Th1/Th2-like immune response | Q33849144 | ||
| A recombinant vaccine expressed in the milk of transgenic mice protects Aotus monkeys from a lethal challenge with Plasmodium falciparum | Q33897645 | ||
| Position-effect protection and enhancer blocking by the chicken beta-globin insulator are separable activities | Q34067751 | ||
| Transgenic animal bioreactors | Q34114603 | ||
| The production of recombinant pharmaceutical proteins in plants. | Q34267406 | ||
| Antibody manufacture in transgenic animals and comparisons with other systems | Q35026023 | ||
| Transgenic rabbits as therapeutic protein bioreactors and human disease models | Q35209836 | ||
| Rotavirus virus-like particles administered mucosally induce protective immunity. | Q35898882 | ||
| Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus. | Q36637672 | ||
| Expression of the major capsid protein VP6 of group C rotavirus and synthesis of chimeric single-shelled particles by using recombinant baculoviruses | Q36702092 | ||
| Assembly of cholera toxin B subunit full-length rotavirus NSP4 fusion protein oligomers in transgenic potato | Q38353887 | ||
| Identification of rotavirus VP6 residues located at the interface with VP2 that are essential for capsid assembly and transcriptase activity | Q39684415 | ||
| Structural polymorphism of the major capsid protein of rotavirus | Q39714820 | ||
| Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins | Q39752998 | ||
| Expression of rotavirus VP2 produces empty corelike particles | Q40064706 | ||
| The future of rotavirus vaccines: a major setback leads to new opportunities | Q40511516 | ||
| Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants | Q40530142 | ||
| Individual rotavirus-like particles containing 120 molecules of fluorescent protein are visible in living cells | Q40805568 | ||
| Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice | Q44572737 | ||
| Expression of rotavirus capsid protein VP6 in transgenic potato and its oral immunogenicity in mice | Q44965400 | ||
| Influence of lactation parameters on the N-glycosylation of recombinant human C1 inhibitor isolated from the milk of transgenic rabbits | Q44978509 | ||
| Intranasal administration of an Escherichia coli-expressed codon-optimized rotavirus VP6 protein induces protection in mice | Q45157629 | ||
| Synthesis of an HIV-1 Tat transduction domain-rotavirus enterotoxin fusion protein in transgenic potato | Q45869454 | ||
| Protective lactogenic immunity conferred by an edible peptide vaccine to bovine rotavirus produced in transgenic plants | Q47289067 | ||
| Association of the 5'HS4 sequence of the chicken beta-globin locus control region with human EF1 alpha gene promoter induces ubiquitous and high expression of human CD55 and CD59 cDNAs in transgenic rabbits | Q48118392 | ||
| The insulator effect of the 5'HS4 region from the beta-globin chicken locus on the rabbit WAP gene promoter activity in transgenic mice. | Q50682512 | ||
| The stimulation of gene expression by the R region from HTLV-1 and BLV. | Q55240031 | ||
| Nasal immunization of mice with a rotavirus DNA vaccine that induces protective intestinal IgA antibodies | Q57223972 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 833-844 | |
| P577 | publication date | 2005-12-01 | |
| P1433 | published in | Transgenic Research | Q7834239 |
| P1476 | title | Production of two vaccinating recombinant rotavirus proteins in the milk of transgenic rabbits | |
| P478 | volume | 14 |
| Q61445443 | A milk-based self-assemble rotavirus VP6-ferritin nanoparticle vaccine elicited protection against the viral infection |
| Q34002966 | Gene-environment interactions influence ecological consequences of transgenic animals |
| Q40127244 | Immune response induced by spike protein from transmissible gastroenteritis coronavirus expressed in mouse mammary cells |
| Q51552437 | Oral administration of plant-based rotavirus VP6 induces antigen-specific IgAs, IgGs and passive protection in mice. |
| Q36944222 | Preparation of recombinant vaccines. |
| Q34744705 | Production of pharmaceutical proteins by transgenic animals |
| Q42719784 | Rabbit milk protein genes: from mRNA identification to chromatin structure. |
| Q80607738 | Recombinant rotavirus inner core proteins produced in the milk of transgenic rabbits confer a high level of protection after intrarectal delivery |
| Q36118124 | The construction and expression of lysine-rich gene in the mammary gland of transgenic mice |
Search more.